Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Disclosure reporting details |
Back to search detail summary
|
:
07/01/2016 - 12/31/2016
|
Authorizing Officer name
|
John
F
Heffernan
|
Title
|
Principal
|
Business name
|
Park Street Strategies, LLC
|
Address
|
30 Rowes Wharf
Suite, 600
|
City, state, zip code
|
Boston , MA 02110
|
Country
|
US
|
Phone
|
617-981-0015
|
|
|
|
|
Compensation/Salaries Paid
|
John F Heffernan
|
$0.00
|
Total salaries paid |
$0.00
|
|
|
Operating Expenses
|
7/1/2016-12/31/2016 |
|
Advertising expenses
|
$0.00
|
7/1/2016-12/31/2016 |
|
Photocopies, scans
|
$0.00
|
7/1/2016-12/31/2016 |
Apple Northshore
|
Computer equipment, supplies
|
$1,963.50
|
7/1/2016-12/31/2016 |
|
Professional dues
|
$0.00
|
7/1/2016-12/31/2016 |
|
Fax charges
|
$0.00
|
7/1/2016-12/31/2016 |
McDermott Ventures
|
Internet fees
|
$180.00
|
7/1/2016-12/31/2016 |
Riley Dever, PC
|
Legal fees
|
$670.00
|
7/1/2016-12/31/2016 |
|
Postage, shipping, delivery
|
$0.00
|
7/1/2016-12/31/2016 |
|
Office supplies, equipment
|
$0.00
|
7/1/2016-12/31/2016 |
|
Printing expenses
|
$0.00
|
7/1/2016-12/31/2016 |
|
Public relations expenses
|
$0.00
|
7/1/2016-12/31/2016 |
McDermott Ventures
|
Rent
|
$13,500.00
|
7/1/2016-12/31/2016 |
|
Office and support staff salaries
|
$0.00
|
7/1/2016-12/31/2016 |
|
Professional subscriptions
|
$0.00
|
7/1/2016-12/31/2016 |
|
Taxes
|
$0.00
|
7/1/2016-12/31/2016 |
AT&T Wireless
|
Telephone, cell phone, handheld
|
$1,293.37
|
7/1/2016-12/31/2016 |
|
Utilities (heat, water, electricity)
|
$0.00
|
7/1/2016-12/31/2016 |
|
Other operating expenses
|
$0.00
|
| | Total operating expenses |
$17,606.87
|
|
|
Activities, Bill Numbers and Titles
|
|
Entity: Park Street Strategies, LLC
|
Client: kaléo
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $5,333.33
|
Senate Bill
|
2010
|
An Act to improve the accessibility and affordability of naloxone and other pharmaceutical drugs of public health concern
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4201
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4450
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4056
|
An Act relative to substance use, treatment, education and prevention
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4200
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
2008
|
Report of the Special Senate Committee on Opioid Addiction Prevention, Treatment and Recovery Options
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements.
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3947
|
an act relative to substance use, treatment, education and prevention
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
4
|
FY17 Senate Ways and Means Budget recommendations
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3926
|
special procedures for consideration of the House bill relative to substance use, treatment, education and prevention
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Entity: Park Street Strategies, LLC
|
Client: UCB, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $21,000.00
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1935
|
An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
519
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
541
|
An Act Concerning out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Entity: Park Street Strategies, LLC
|
Client: Shire
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $30,000.00
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2103
|
An act relative to substance use, treatment, education and prevention (Conf. Comm.)
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4056
|
An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1935
|
An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2709
|
An Act designating the last day in February as Rare Disease Day in the Commonwealth
|
Support
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |
|
Entity: Park Street Strategies, LLC
|
Client: Massachusetts Biotechnology Council
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $60,000.00
|
Senate Bill
|
2313
|
An Act Relative to the Dispensing of Certain Cancer Related Drugs
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1042
|
An Act relative to responsible stewardship by drug manufacturers
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4434
|
An Act relative to the judicial enforcement of noncompetition agreements
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3465
|
An Act relative to patient access
|
Support
|
$0.00
|
n/a
|
House Bill
|
1761
|
An Act Relative to the Prohibition of Non-competition Agreements
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
2305
|
Senate Final FY2017 Budget Recommendations (engrossed)
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1031
|
An act to improve medication adherence
|
Support
|
$0.00
|
n/a
|
House Bill
|
4432
|
An Act to relative to job creation, workforce development and infrastructure investment
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3270
|
An Act Establishing a Right to Try
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1719
|
An Act Relative to the Prohibition of Non-competition Agreements
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
2010
|
An Act to improve the accessibility and affordability of naloxone and other pharmaceutical drugs of public health concern
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
625
|
An act relative to patient access
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4201
|
House Final FY 2017 Budget (engrossed)
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2072
|
An Act ensuring a representative health care cost containment discussion
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
828
|
An Act Relative to patient financial protection
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1188
|
An Act to reduce health care costs by promoting evidence-based prescriber education
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
579
|
An act to establish Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
3983
|
An Act to provide opportunities for all
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1945
|
An Act promoting research and protecting public safety and environment
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1187
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
563
|
An act to increase health insurer reporting transparency
|
Support
|
$0.00
|
n/a
|
House Bill
|
2
|
FY 17 Budget - Gov
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1935
|
An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Chapter 441, An Act regulating pharmacy audits
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1165
|
An Act Relative to the Dispensing of Certain Cancer Related Drugs
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
178
|
An Act protecting Massachusetts businesses from abusive patent infringement claims
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
3926
|
An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1908
|
An Act relative to prescription recycling
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
4
|
SWM FY 2017 Budget Recommendations
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1002
|
An Act to Enhance Employment Opportunities
|
Support
|
$0.00
|
n/a
|
House Bill
|
4413
|
An Act to relative to job creation, workforce development and infrastructure investment
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3242
|
An Act establishing the Genetic Engineering Transparency Food and Seed Labeling Act
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1701
|
An act relative to the judicial enforcement of non-compete agreements
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
1233
|
An Act establishing and financing a drug collection and disposal program
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
581
|
An act to ensure access to medications
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4056
|
An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1977
|
An Act to Create a Massachusetts Rare Disease Advisory Council
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
791
|
An Act Relative to Patient Medication Adherence
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
1524
|
An Act closing a corporate tax haven loophole
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
607
|
An Act relative to Health Policy Commission oversight of insurer transactions
|
Support
|
$0.00
|
n/a
|
House Bill
|
4200
|
HWM FY 2017 Budget
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2059
|
An act to establishing a statewide discount program for pharmaceuticals
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
792
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
Executive
|
|
M.G.L. c.176O, §25 - Development of Standard Prior Authorization Forms
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1158
|
An Act relative to liability for genetically engineered food
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
169
|
An Act to protect trade secrets and eliminate non-compete agreements
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
3817
|
An Act Relative to Substance Use Treatment
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1894
|
An Act relative to retail pharmacy discounts and co-pay assistance.
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
2103
|
An act relative to substance use, treatment, education and prevention (Conf. Comm.)
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
957
|
An act relative to the judicial enforcement of non-compete agreements
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4323
|
An Act relative to the judicial enforcement of noncompetition agreements
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2709
|
An Act designating the last day in February as Rare Disease Day in the Commonwealth
|
Support
|
$0.00
|
n/a
|
House Bill
|
976
|
An Act further regulating the substitution of interchangeable biosimilars
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
1508
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
605
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4156
|
An Act establishing the genetic engineering transparency food labeling act
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
2013
|
An act to improve health planning & public health
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
792
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
2020
|
An Act relative to substance use prevention
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
639
|
An act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4272
|
An Act relative to protecting health care consumers
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2477
|
An Act closing a certain corporate tax haven loophole
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
870
|
An act to ensure access to generic medications
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Ch. 52, Acts of 2016, An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1177
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
519
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
House Bill
|
3944
|
An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1922
|
An Act relative to tests of newborn children for treatable disorders or diseases
|
Support
|
$0.00
|
n/a
|
Executive
|
|
Ch. 224, Acts of 2012, An Act Improving the Quality of Health Care and Reducing Costs Through Increased Transparency, Efficiency, and Innovation
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1045
|
An act preventing prescription drug abuse by closing the pharmacy shopping loophole
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4450
|
FY2017 Budget Conference Committee Report
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3678
|
An Act relative to protecting health care consumers
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1807
|
An act relative to HPC oversight of insurer transactions
|
Support
|
$0.00
|
n/a
|
Executive
|
|
105 CMR 700.000 Implementation of MGL c. 94C, Controlled Substances Act
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1186
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
541
|
An Act Concerning out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
An Act Concerning out-of-pocket expenses for prescription drug coverage
|
House Bill
|
3947
|
An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1925
|
An act establishing provisions for the return of expired pharmaceuticals
|
Oppose
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |
|
Entity: Park Street Strategies, LLC
|
Client: Biotechnology Innovation Organization (BIO)
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $20,000.00
|
House Bill
|
1807
|
An act relative to HPC oversight of insurer transactions
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
519
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
639
|
An act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1807
|
An act relative to HPC oversight of insurer transactions
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
541
|
An Act Concerning out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
605
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1945
|
An Act promoting research and protecting public safety and environment
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Chapter 441, An Act regulating pharmacy audits
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3465
|
An Act relative to patient access
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
1177
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
791
|
An Act Relative to Patient Medication Adherence
|
Support
|
$0.00
|
n/a
|
House Bill
|
2
|
FY 17 Budget - Gov
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1158
|
An Act relative to liability for genetically engineered food
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
870
|
An act to ensure access to generic medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4201
|
House Final FY 2017 Budget (engrossed)
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1177
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1894
|
An Act relative to retail pharmacy discounts and co-pay assistance.
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
563
|
An act to increase health insurer reporting transparency
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
581
|
An act to ensure access to medications
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3270
|
An Act Establishing a Right to Try
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
2017
|
SWM FY 2017 Budget Recommendations
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
2059
|
An act to establishing a statewide discount program for pharmaceuticals
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Ch. 224, Acts of 2012, An Act Improving the Quality of Health Care and Reducing Costs Through Increased Transparency, Efficiency, and Innovation
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
976
|
An Act further regulating the substitution of interchangeable biosimilars
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
169
|
An Act to protect trade secrets and eliminate non-compete agreements
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
1042
|
An Act relative to responsible stewardship by drug manufacturers
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1908
|
An Act relative to prescription recycling
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
105 CMR 700.000 Implementation of MGL c. 94C, Controlled Substances Act
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
579
|
An act to establish Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
3242
|
An Act establishing the Genetic Engineering Transparency Food and Seed Labeling Act
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
2305
|
Senate Final FY2017 Budget Recommendations (engrossed)
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1925
|
An act establishing provisions for the return of expired pharmaceuticals
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Ch. 52, Acts of 2016, An Act Relative to Substance Use, Treatment, Education and Prevention
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
563
|
An act to increase health insurer reporting transparency
|
Support
|
$0.00
|
n/a
|
House Bill
|
828
|
An Act Relative to patient financial protection
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4200
|
HWM FY 2017 Budget
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1186
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1701
|
An act relative to the judicial enforcement of non-compete agreements
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
178
|
An Act protecting Massachusetts businesses from abusive patent infringement claims
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1031
|
An act to improve medication adherence
|
Support
|
$0.00
|
n/a
|
House Bill
|
792
|
An act relative to ensuring transparency of health plans formularies
|
Support
|
$0.00
|
n/a
|
House Bill
|
4156
|
An Act establishing the genetic engineering transparency food labeling act
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
1233
|
An Act establishing and financing a drug collection and disposal program
|
Oppose
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
07/18/2016 | Park Street Strategies, LLC |
Travel
|
parking Boston Common Garage
|
John Heffernan, 30 Rowes Wharf, Boston MA; Katie Joyce, 1 Shire Way. Lexington MA
|
$28.00
|
08/04/2016 | Park Street Strategies, LLC |
Meal
|
Jerry Remy's Restaurant
|
John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA
|
$89.90
|
09/19/2016 | Park Street Strategies, LLC |
Travel
|
PI Alley Parking
|
John Heffernan,30 Rowes wharf, Boston MA, John Prestidge, 3000 Hanover Street, Palo alto, CA, Charles Desourdy, 1 Ashburton Place, Boston MA
|
$38.00
|
09/21/2016 | Park Street Strategies, LLC |
Travel
|
LAZ Parking Boston MA
|
John Heffernan, 30 Rowes Wharf, Boston MA, William Cass, 24 School Street, Boston MA
|
$40.00
|
10/13/2016 | Park Street Strategies, LLC |
Travel
|
Uber to 300 Technology Sq.
|
John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA
|
$10.71
|
10/20/2016 | Park Street Strategies, LLC |
Travel
|
parking - PI Alley Garage
|
Matt Harutunian, 1950 Lake Park Drive, Smyrna GA;William McDermott, 30 rowes Wharf, Boston MA, John Heffernan, 30 rowes Wharf, Boston MA
|
$30.00
|
10/31/2016 | Park Street Strategies, LLC |
Travel
|
Technology Sq. Parking
|
Robert Coughlin, 300 Technology Sq., Cambridge, MA; John Heffernan, 30 Rowes Wharf, Boston MA
|
$25.00
|
11/01/2016 | Park Street Strategies, LLC |
Travel
|
Boston parking
|
John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA; Raymond Campbell, 500 Boylston St., Boston, MA; Pat Cerundolo, 155 Seaport Blvd. Boston MA
|
$2.65
|
11/10/2016 | Park Street Strategies, LLC |
Travel
|
MB TA Parking and fare
|
John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA
|
$7.25
|
12/12/2016 | Park Street Strategies, LLC |
Travel
|
technology Sq parking
|
Ronald Mariano, State House Boston, MA; John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA
|
$25.00
|
12/12/2016 | Park Street Strategies, LLC |
Travel
|
technology Sq parking
|
Stanley Rosenberg, State House Boston, MA; John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA
|
$25.00
|
12/13/2016 | Park Street Strategies, LLC |
Travel
|
Parking Boston Common
|
John Heffernan30 Rowes Wharf, Boston MA, Michael Day, State House Boston MA,Matt Harutunian, 1950 Lake Park Drive, Smyrna GA
|
$28.00
|
12/21/2016 | Park Street Strategies, LLC |
Travel
|
Boston parking
|
John Heffernan, 30 Rowes Wharf, Boston MA; Joseph Boncore, State House Boston, MA; Anthony Gesualdi, Sate House, Boston MA
|
$2.65
|
| | | | Total amount |
$352.16
|
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
07/12/2016 | John F Heffernan |
Michael Moran
|
Representative - 18th Suffolk
|
$200.00
|
07/14/2016 | John F Heffernan |
Michael Rodrigues
|
Senator - 1st Bristol and Plymouth
|
$200.00
|
08/24/2016 | John F Heffernan |
Walter Timilty
|
Senator - Norfolk, Bristol, Plymouth
|
$200.00
|
09/21/2016 | John F Heffernan |
Aaron Michlewitz
|
Representative - 3rd Suffolk
|
$200.00
|
10/04/2016 | John F Heffernan |
Charlie Baker
|
Governor
|
$200.00
|
10/20/2016 | John F Heffernan |
Julian Cyr
|
Senator - Cape and Islands
|
$100.00
|
12/12/2016 | John F Heffernan |
Stanley Rosenberg
|
Senator - Hampshire, Franklin, Worcester
|
$200.00
|
| | | Total contributions |
$1,300.00
|
|
|
|
|